Cancer bio-repository

Background: Cancer research is highly dependent of large amount of data and high quality samples which can be provided by networks to enable large-scale multi-center research projects. Biologic materials, such as blood, tissue samples, DNA, body fluids and the related data obtained in cohorts and cl...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Shima Fakher, Seyed Vahid Hosseini, Mozhdeh Zamani, Leila Ghahramani, Pooneh mokaram Mokaram
Formato: article
Lenguaje:EN
Publicado: Shiraz University of Medical Sciences 2019
Materias:
R
Acceso en línea:https://doaj.org/article/1331d827168048a08905a31a8fee206c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1331d827168048a08905a31a8fee206c
record_format dspace
spelling oai:doaj.org-article:1331d827168048a08905a31a8fee206c2021-11-14T08:42:28ZCancer bio-repository2783-243010.30476/acrr.2019.46388https://doaj.org/article/1331d827168048a08905a31a8fee206c2019-12-01T00:00:00Zhttps://colorectalresearch.sums.ac.ir/article_46388_36d0110cd2ea1fb0526cc144dd280803.pdfhttps://doaj.org/toc/2783-2430Background: Cancer research is highly dependent of large amount of data and high quality samples which can be provided by networks to enable large-scale multi-center research projects. Biologic materials, such as blood, tissue samples, DNA, body fluids and the related data obtained in cohorts and clinical trials are valuable sources for research which should be managed by policies and standard operating procedures as biorepositories or biobanks. Methods and evidence acquisition: The authors investigated and summarized pubmed database articles using biobanks and describing the policies. Conclusion: biobanking as a young discipline in different countries needs new technologies, standards and harmonization. In this review article, we have an overview on biorepository, cancer biobanking and the emerging registry in Iran. Background: Cancer research is highly dependent of large amount of data and high quality samples which can be provided by networks to enable large-scale multi-center research projects. Biologic materials, such as blood, tissue samples, DNA, body fluids and the related data obtained in cohorts and clinical trials are valuable sources for research which should be managed by policies and standard operating procedures as biorepositories or biobanks. Methods and evidence acquisition: The authors investigated and summarized pubmed database articles using biobanks and describing the policies. Conclusion: biobanking as a young discipline in different countries needs new technologies, standards and harmonization. In this review article, we have an overview on biorepository, cancer biobanking and the emerging registry in Iran.Shima FakherSeyed Vahid HosseiniMozhdeh ZamaniLeila GhahramaniPooneh mokaram MokaramShiraz University of Medical Sciencesarticlebiobankbiorepositorybiobank networkcolorectal cancerMedicineRENIranian Journal of Colorectal Research, Vol 7, Iss 4, Pp 1-4 (2019)
institution DOAJ
collection DOAJ
language EN
topic biobank
biorepository
biobank network
colorectal cancer
Medicine
R
spellingShingle biobank
biorepository
biobank network
colorectal cancer
Medicine
R
Shima Fakher
Seyed Vahid Hosseini
Mozhdeh Zamani
Leila Ghahramani
Pooneh mokaram Mokaram
Cancer bio-repository
description Background: Cancer research is highly dependent of large amount of data and high quality samples which can be provided by networks to enable large-scale multi-center research projects. Biologic materials, such as blood, tissue samples, DNA, body fluids and the related data obtained in cohorts and clinical trials are valuable sources for research which should be managed by policies and standard operating procedures as biorepositories or biobanks. Methods and evidence acquisition: The authors investigated and summarized pubmed database articles using biobanks and describing the policies. Conclusion: biobanking as a young discipline in different countries needs new technologies, standards and harmonization. In this review article, we have an overview on biorepository, cancer biobanking and the emerging registry in Iran. Background: Cancer research is highly dependent of large amount of data and high quality samples which can be provided by networks to enable large-scale multi-center research projects. Biologic materials, such as blood, tissue samples, DNA, body fluids and the related data obtained in cohorts and clinical trials are valuable sources for research which should be managed by policies and standard operating procedures as biorepositories or biobanks. Methods and evidence acquisition: The authors investigated and summarized pubmed database articles using biobanks and describing the policies. Conclusion: biobanking as a young discipline in different countries needs new technologies, standards and harmonization. In this review article, we have an overview on biorepository, cancer biobanking and the emerging registry in Iran.
format article
author Shima Fakher
Seyed Vahid Hosseini
Mozhdeh Zamani
Leila Ghahramani
Pooneh mokaram Mokaram
author_facet Shima Fakher
Seyed Vahid Hosseini
Mozhdeh Zamani
Leila Ghahramani
Pooneh mokaram Mokaram
author_sort Shima Fakher
title Cancer bio-repository
title_short Cancer bio-repository
title_full Cancer bio-repository
title_fullStr Cancer bio-repository
title_full_unstemmed Cancer bio-repository
title_sort cancer bio-repository
publisher Shiraz University of Medical Sciences
publishDate 2019
url https://doaj.org/article/1331d827168048a08905a31a8fee206c
work_keys_str_mv AT shimafakher cancerbiorepository
AT seyedvahidhosseini cancerbiorepository
AT mozhdehzamani cancerbiorepository
AT leilaghahramani cancerbiorepository
AT poonehmokarammokaram cancerbiorepository
_version_ 1718429759950553088